Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences (BUMS), Birjand, Iran.
J Interferon Cytokine Res. 2023 Apr;43(4):147-163. doi: 10.1089/jir.2022.0185.
Cytokine storm refers to the overproduction of immune and inflammatory cells and their proteins (cytokines) [interleukin (IL)-1 and IL-6] causing acute respiratory distress syndrome in COVID-19. COVID-19 causes inflammatory reactions, and patients with COVID-19 had categorized as mild, severe, and critical after reviewing previous studies. Then, it is crucial to find immune-inflammatory indicators that might predict the disorder severity and the prognosis primarily for guiding medical therapy in the face of this unexpectedly developing unique infectious disease. Higher levels of IL-6 and IL-1 levels might be seen in patients with COVID-19 at each stage. In addition, IL-1-induced IL-6 assists in the synthesis of liver C-reactive protein (CRP) in acute phase responses. Recent studies suggested that IL-6 levels are an independent predictor of COVID-19 illness because they were significantly higher in patients with severe than with mild COVID-19 symptoms. Anakinra and tocilizumab (TCZ) are beneficial in lowing mortality in COVID-19 patients; however, information on their safety and efficacy is scarce. The aim of this study was to investigate the role of inflammatory cytokines (IL-1 and IL-6) as potential biomarkers in the different stages (mild, severe, and critical) of COVID-19. A systematic search during the years 2021-2022 using the keywords SARS-CoV-2, COVID-19, IL-6, IL-1, CRP, mild stage, severe stage, critical stage, cytokine storm, tocilizumab, and anakinra was performed in PubMed and Google Scholar databases. This study reviews studies that have investigated the role of high levels of these cytokines in the severity of the disease in patients with COVID-19 and the inhibitory function of TCZ and anakinra in preventing mechanical ventilation and patient mortality. According to the result, studies suggest that decreased innate immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in association with the production of inflammatory cytokines is the determining and driving function of COVID-19.
细胞因子风暴是指免疫和炎症细胞及其蛋白(细胞因子)[白细胞介素 (IL)-1 和 IL-6]过度产生,导致 COVID-19 中的急性呼吸窘迫综合征。COVID-19 引起炎症反应,根据之前的研究,COVID-19 患者可分为轻症、重症和危重症。因此,寻找可能预测疾病严重程度和预后的免疫炎症指标至关重要,主要是为了在面对这种意外出现的独特传染病时指导医疗治疗。在每个阶段,COVID-19 患者的 IL-6 和 IL-1 水平可能更高。此外,IL-1 诱导的 IL-6 有助于在急性期反应中合成肝脏 C 反应蛋白 (CRP)。最近的研究表明,IL-6 水平是 COVID-19 疾病的独立预测因子,因为重症 COVID-19 患者的 IL-6 水平明显高于轻症 COVID-19 患者。阿那白滞素和托珠单抗 (TCZ) 可降低 COVID-19 患者的死亡率;然而,关于它们的安全性和疗效的信息很少。本研究旨在探讨炎症细胞因子 (IL-1 和 IL-6) 作为 COVID-19 不同阶段(轻症、重症和危重症)潜在生物标志物的作用。在 2021 年至 2022 年期间,使用 SARS-CoV-2、COVID-19、IL-6、IL-1、CRP、轻症、重症、危重症、细胞因子风暴、TCZ 和阿那白滞素等关键词在 PubMed 和 Google Scholar 数据库中进行了系统搜索。本研究综述了研究表明,高水平的这些细胞因子在 COVID-19 患者疾病严重程度中的作用以及 TCZ 和阿那白滞素在预防机械通气和患者死亡率方面的抑制功能。研究表明,对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 的固有免疫反应降低与炎症细胞因子的产生是 COVID-19 的决定和驱动因素。